5 Key Takeaways

• 1

  Contact lenses have undergone a significant regulatory journey, highlighted in a special commemorative edition of Contact Lens Spectrum.

• 2

  The Medical Device Amendments of 1976 classified contact lenses as medical devices, establishing distinct regulatory pathways.

• 3

  Historically, PMMA lenses had minimal regulatory oversight compared to the increased scrutiny of soft contact lenses.

• 4

  Regulatory oversight influences clinical decisions, including off-label use and prescription verification under the Contact Lens Rule.

• 5

  Emerging technologies like smart contact lenses and drug-eluting systems are reshaping the intersection of regulatory policy and clinical practice.